Warmuth Markus bought GLUE
January 2, 2026 · Form 4 insider transaction
Warmuth Markus bought 406,000 shares of Monte Rosa Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
406,000
Price
$0.00
Total value
N/A
InsiderWarmuth Markus
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after406,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of this option shall vest and become exercisable on January 2, 2027, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.